Addressing the Challenges of Type II Diabetes Global Clinical Trials

Presented by

Dr. Martin Benson, Senior Director & Global Lead, Cardiometabolic Drug Development Services, ICON

About this talk

Addressing the challenges of Type II Diabetes global clinical trials via use of high quality laboratory solutions Join ICON’s expert Dr. Andrew Roche, PhD as he speaks about overcoming challenges when developing Diabetes trials. Addressing these challenges via use of high quality tools is critical to successful completion of a clinical trial. The webinar will focus on specific analytical test solutions for Type II Diabetes that enable the creation of high quality laboratory data sets which in turn enable an accurate and efficient assessment of the test compound. It is the belief of ICON Central Laboratories that these considered solutions will provide high quality options that will increase the opportunity for success for those undertaking the challenge posed by drug development. Key Insights that will be covered The creation of high quality laboratory data sets as a means of enabling an accurate and efficient assessment of the test compound. Understanding the value of global laboratory harmonisation when performing global clinical trial. Accurately defining clinical status via laboratory endpoints. Speakers: Dr. Martin Benson, Senior Director & Global Lead, Cardiometabolic Drug Development Services, ICON; Dr. Andrew Roche, Scientific Director, Global Validation, ICON

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (35)
Subscribers (496)
BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges when it comes to developing their drug or device. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.